A new study has found the number of Australian adults infected with COVID-19 at the end of February 2022, was at least twice as high as cases reported to authorities.
The number of teenage girls who presented to NSW Emergency Departments (ED) for self-harm or suicidal ideation has dramatically escalated during the pandemic, following a steady increase over the past decade.
The first ever clinical practice guidelines for children with Charcot-Marie-Tooth disease (CMT) have been published after a decade of work by an international team.
Two young sisters with a blinding eye condition will now have access to ocular gene therapy after a new pathway to the treatment was discovered.
Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early variants in 2020 produced sustained antibodies, however, these antibodies are not as effective against contemporary variants of the virus.
A new international treatment guideline for the most common single form of encephalitis in children is set to change clinical practice and impact children worldwide. Kids Neuroscience Centre Clinical Director, Professor Russell Dale led the study, bringing together 25 experts from around the world to standardise treatment.
A major milestone in the treatment of kidney disease is detailed in a recently published study, pulled together by first year medical student, Hope Tanudisastro and led by the team at Centre for Kidney Research at Kids Research.
Deep Brain Stimulation is a cutting-edge neurosurgical treatment that may help improve disability and quality of life in selected children with cerebral palsy due to genetic conditions or birth injury. The Kids Neuroscience Centre research team examined the suitability for DBS to eligible children.
Recent studies by the Kids Neuroscience Centre have highlighted the clinical significance of the antibodies that cause spinal inflammation. These findings recently helped a three-year-old child, James, get back on his feet after losing his ability to walk.
Families and doctors looking after children with a rare form of cerebral palsy, associated with a gene called ADCY5, have chanced upon a precision therapy that is making lives easier for these children. The team at the Kids Neuroscience Centre are now guiding eligible patients to trial caffeine.